phase readout
saveNCT06905834: Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments
NOT_YET_RECRUITINGupdated 41m ago
community read0 votes
Sponsor: Instituto de Investigación Biomédica de Salamanca. Phase: PHASE2. Conditions: Dry Eye Disease (DED), Graft-Versus-Host Disease(GVHD)
view source ↗
comments(0)
5-min edit window · permanent after that